1-3 of 3
John A. Barrett
Close
Sort by
Journal Articles

CD19-Specific Chimeric Antigen Receptor-Modified T Cells with Safety Switch Produced Under "Point-of-Care" Using the Sleeping Beauty System for the Very Rapid Manufacture and Treatment of B-Cell Malignancies

Tim Chan, PhD, John Gallagher, Nai-Lin Cheng, PhD, Fernando Carvajal-Borda, DVM, Jacques Plummer, Adeline Govekung, John A Barrett, PhD, Pranay D. Khare, PhD, Laurence J N Cooper, MDPhD, Rutul R Shah
Journal: Blood
Blood (2017) 130 (Supplement 1): 1324.
https://doi.org/10.1182/blood.V130.Suppl_1.1324.1324
Published: 2017
Journal Articles

Evaluation of Three Different Cyclosporine-Based Graft Versus Host Disease (GVHD) Prophylaxis Regimens Following Nonmyeloablative Hematopoietic Stem Cell Transplantation (NST).

Ramaprasad Srinivasan, MD, PhD, Nancy Geller, PhD, Sakti Chakrabarti, MD, Igor Espinoza-Delgado, MD, Teresa Donohue, Susan Leitman, MD, Charles D. Bolan, MD, Elizabeth J. Read, MD, John A. Barrett, MD, Richard W. Childs, MD
Journal: Blood
Blood (2004) 104 (11): 1236.
https://doi.org/10.1182/blood.V104.11.1236.1236
Published: 2004
Journal Articles

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome

Jaroslaw P. Maciejewski, Dean Follmann, Ryotaro Nakamura, Yogen Saunthararajah, Candido E. Rivera, Toni Simonis, Kevin E. Brown, John A. Barrett, Neal S. Young
Journal: Blood
Blood (2001) 98 (13): 3513–3519.
https://doi.org/10.1182/blood.V98.13.3513
Published: 2001